申请人:Proteostasis Therapeutics, Inc.
公开号:US20160333031A1
公开(公告)日:2016-11-17
The present invention is directed to compounds having the Formula (I), (II), (III), (IV), and (V), compositions thereof, and methods for the treatment of a condition associated with a dysfunction in proteostasis.